Wilma F. Bergfeld

ORCID: 0000-0002-5981-3925
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Contact Dermatitis and Allergies
  • Effects and risks of endocrine disrupting chemicals
  • Hair Growth and Disorders
  • Pesticide Exposure and Toxicity
  • Dermatologic Treatments and Research
  • Cancer and Skin Lesions
  • Cutaneous lymphoproliferative disorders research
  • Autoimmune Bullous Skin Diseases
  • Skin Protection and Aging
  • Nail Diseases and Treatments
  • Carcinogens and Genotoxicity Assessment
  • Dermatology and Skin Diseases
  • Polymer Science and PVC
  • Agricultural safety and regulations
  • Cutaneous Melanoma Detection and Management
  • Genetic and rare skin diseases.
  • Nonmelanoma Skin Cancer Studies
  • melanin and skin pigmentation
  • Antimicrobial agents and applications
  • Eosinophilic Disorders and Syndromes
  • Skin and Cellular Biology Research
  • RNA regulation and disease
  • Chemical Safety and Risk Management
  • Autoimmune and Inflammatory Disorders
  • Soft tissue tumor case studies

Cleveland Clinic
2016-2025

Medical University of South Carolina
2022-2023

UConn Health
2022-2023

American Academy of Dermatology
1995-2023

Cleveland Clinic Lerner College of Medicine
2009-2023

Case Western Reserve University
2009-2023

Mental Illness Fellowship
2023

North American Hair Research Society
2019-2021

Oxfam
2018

John Wiley & Sons (United States)
2018

Male and female pattern hair loss are common, chronic dermatologic disorders with limited therapeutic options. In recent years, a number of commercial devices using low-level laser therapy have been promoted, but there little peer-reviewed data on their efficacy.To determine whether treatment device, the US FDA-cleared HairMax Lasercomb®, increases terminal density in both men women loss.Randomized, sham device-controlled, double-blind clinical trials were conducted at multiple institutional...

10.1007/s40257-013-0060-6 article EN cc-by-nc American Journal of Clinical Dermatology 2014-01-28

Hyaluronic acid, sodium hyaluronate, and potassium hyaluronate function in cosmetics as skin conditioning agents at concentrations up to 2%. primarily obtained from bacterial fermentation rooster combs, does penetrate the dermis. acid was not toxic a wide range of acute animal toxicity studies, over several species with different exposure routes. immunogenic, nor it sensitizer studies. reproductive or developmental toxicant. genotoxic. likely play causal role cancer metastasis; rather,...

10.1177/1091581809337738 article EN International Journal of Toxicology 2009-07-01

Treatment of Alopecia Areata With Tofacitinib2][3] In this study, investigators searched the medical records Cleveland Clinic for any patients with confirmed AA who were treated oral tofacitinib (Xeljanz; Pfizer) using a standardized, systematic treatment regimen.

10.1001/jamadermatol.2017.0001 article EN JAMA Dermatology 2017-03-29

Twelve cases were reviewed of squamous cell carcinoma the nail bed, with emphasis on aetiological role human papillomavirus (HPV) infection and radiation damage. Using a hybridization technique, similar HPV genomes detected in uterine cervical neoplasia subungual same patient.

10.1111/j.1365-2133.1990.tb01849.x article EN British Journal of Dermatology 1990-08-01

Methylisothiazolinone (MIT) is a heterocyclic organic compound used as preservative in cosmetics and personal care products concentrations up to 0.01%. MIT colorless, clear liquid with mild odor that completely soluble water; mostly acetonitrile, methanol, hexane; slightly xylene. Consistent its solubility, dermal penetration low. The Cosmetic Ingredient Review Expert Panel noted the vitro evidence of neurotoxicity but concluded absence any findings many vivo studies, including subchronic,...

10.1177/1091581810374651 article EN International Journal of Toxicology 2010-05-01

The CIR Expert Panel (Panel) assessed the safety of citric acid, 12 inorganic citrate salts, and 20 alkyl esters as used in cosmetics, concluding that these ingredients are safe present practices use concentration. Citric acid is reported to function a pH adjuster, chelating agent, or fragrance ingredient. Some salts also agents, number citrates skin-conditioning agents but other functions reported. reviewed available animal clinical data, because calcium citrate, ferric manganese potassium...

10.1177/1091581814526891 article EN International Journal of Toxicology 2014-05-01
Coming Soon ...